MO
Markus Opitz
Manager Stability And Release Analytics at Basilea Pharmaceutica
View Markus's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Manager Stability And Release Analytics
Nov 2017 - Present · 7 years and 1 months
Global Product Steward
Oct 2015 - Oct 2017 · 2 years
Novartis Animal Health now Elanco Animal Health
Third Party Qa Manager
Mar 2012 - Sep 2015 · 3 years and 6 months
Company Details
51-200 Employees
Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in the heart of the life sciences hub of Basel area, Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands: Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. In addition, we have several preclinical anti-infective assets in our portfolio. Basilea currently has about 150 employees and is listed on the SIX Swiss Exchange (SIX: BSLN). Please visit basilea.com.
Year Founded
2000
Social Media
Linkedin
Industry
Biotechnology Research, Cancer research, Research and testing, IT, Internet, R&D, Dermatology research and development, Allergy research, Pharmaceuticals research and development, Medical and pharmaceutical research, Antibacterial pharmaceuticals, Health, medical and pharmaceutical
HQ Location
Hegenheimermattweg 167b Allschwil, Basel-Country 4123, CH
Keywords
PharmaceuticalsBiopharmMRSA
Discover More About Cleveland Clinic

Find verified contacts of Markus Opitz in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.